PSPedro Nonato da Junior Silva

Pedro Nonato da Junior Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pedro Nonato da Junior Silva has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Conformational Preferences of the Trypanocidal Drug Benznidazole by DFT-Guided Vibrational Spectroscopy

    by Eveline M. Bezerra, Pedro N. Silva Junior, Taciano A. Sorrentino, Francisco A. M. Sales, Alice M. C. Martins, Ricardo P. Santos, Ewerton W. S. Caetano, Valder N. Freire, Roner F. da Costa

    Chagas disease remains a major neglected parasitic illness in Latin America and other endemic regions, and benznidazole (BZN) is still the primary trypanosomacidal drug despite its incompletely understood mechanism of action. This work provides a detailed biophysical characterization of the conformational behavior and vibrational properties of benznidazole (BZN), a first-line trypanocidal drug still widely used for the treatment of Chagas disease. Using density functional theory combined with relaxed potential energy surface scans in vacuum and implicit water, two low-energy conformers (BZN1 and BZN2) were identified, separated by moderate rotational barriers and a small energy difference, indicating that both are intrinsically accessible at room temperature. For each conformer, infrared and Raman spectra were calculated and assigned via vibrational mode analysis, then compared with FT-IR and FT-Raman spectra recorded for pharmaceutical-grade polycrystalline BZN. The theoretical and experimental spectra show excellent agreement, with a Raman band in the 1350–1400 cm−1 region emerging as a sensitive conformational marker: the experimental maximum at 1359cm−1 matches the most intense BZN1 mode, whereas the corresponding BZN2 band appears about 13cm−1 higher in frequency. This clear spectroscopic fingerprint demonstrates that the solid drug is overwhelmingly composed of the BZN1 conformer, despite the theoretical accessibility of BZN2. Overall, the study links the conformational landscape of benznidazole to its vibrational signatures and highlights Raman spectroscopy, supported by quantum chemical calculations, as a powerful tool for conformational and potential polymorphic control of this clinically important nitroimidazole.

  • Open Access

    Susceptibility profile of Staphylococcus aureus isolates in blood cultures from a tertiary hospital - comparison of methods for determination of minimum inhibitory concentration of vancomycin

    by Rejane Moraes Falcão, Ana Júlia Batista Pereira, Natasha Maria Lima Pinheiro, Pedro Nonato da Junior Silva, Ítalo Costa Monteiro, Francisco Janeto Lopes Filho Dantas, Bruna Ribeiro Duque, Izabell Maria Martins Teixeira, Mac Dionys Rodrigues Da Costa, Emanuel Paula Magalhães, et al.

    Objective: to evaluate the antimicrobial susceptibility profile of Staphylococcus aureus isolates from blood cultures and compare methods for determiningthe minimum inhibitory concentration (MIC) of vancomycin. Methods: an observational study conducted in a tertiary hospital, involving 62 clinical isolates of S. aureus. In addition, the MIC of vancomycin was determined using the Etest®, broth microdilution (BMD), and Vitek® automated system methods. Clinically relevant antimicrobial susceptibility profiles were evaluated, and agreement between methods was analyzed by statistical correlationusing IBM-SPSS® software. The study was approved by the hospital's Research Ethics Committee under registration number 5.557.687/2022. Results: methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) isolates were susceptible to vancomycin, teicoplanin, linezolid, daptomycin, and tigecycline. A better correlation was observed between the vancomycin MIC values obtained by Vitek®2 and BMD compared to Etest®. However, Vitek®2 tended to overestimate MIC compared to BMD. Conclusion: the results indicate the importance of using complementary methods to validate high vancomycin MIC values, contributing to more appropriate therapeutic decisions and the prevention of bacterial resistance.

  • Effect from dinoponeratoxin M-PONTXDq3a arginine and lysine substituted analogues against Staphylococcus aureus strains

    by Pedro Nonato da Silva Júnior, João Victor Serra Nunes, Bruna Ribeiro Duque, Ana Júlia Batista Pereira, Emanuel Paula Magalhães, Cyntia Silva Oliveira, Katielle Albuquerque Freire, Cibele Nicolaski Pedron, Vani Xavier Oliveira, Tiago Lima Sampaio, et al.